India, Jan. 19 -- Organisations behind the vaccine arm seem to be losing interest in COVID-19

Talk of new pandemics of unknown origin is escalating and hopes are pinned on the systems set to deal with COVID-19. These systems include COVAX, the vaccine arm of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April 2020.

COVAX hogged the limelight through the pandemic as effective vaccines can prevent morbidity and mortality. The facility is the brainchild of Gavi-the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), World Health Organization (WHO) and United Nations Children's Fund (UNICEF).

Read more: COVID-19 Vaccine Watch: COVAX has 2 billion doses to supply to 190 countries

COVAX was ...